Securities Registration (section 12(g)) (8-a12g)
June 13 2013 - 6:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
____________________
IMMUNOTECH
LABORATORIES, INC
.
(Exact Name of Registrant as Specified in Its
Charter)
Nevada
(State of Incorporation or Organization)
95-4834274
(I.R.S. Employer
Identification No.)
120 W. Pomona Avenue
Monrovia, CA
|
|
91016
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following
box.
¨
If this Form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following
box.
x
Securities Act registration statement file number to which this
form relates:
333-57514
(if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
|
Title of Each Class
to be so Registered
|
Common Stock, par value $0.0001
|
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1.
|
DESCRIPTION OF REGISTRANT’S SECURITIES TO BE REGISTERED
|
This Registration Statement
relates to the registration with the Securities and Exchange Commission of shares of Common Stock, par value $0.0001 (the “Common
Stock”), of Immunotech Laboratories, Inc., a Nevada corporation (the “Registrant”). The description of the Common
Stock to be registered hereunder set forth under the caption “Description of Offering” in the Registrant’s Registration
Statement on Form SB-2, Registration No.
333-57514
(the “Registration Statement”),
filed with the Securities and Exchange Commission, as amended, and is incorporated herein by this reference.
The following exhibits
are filed or incorporated by reference to the Registration Statement:
3.1 (1)
|
|
Articles of Incorporation
|
|
|
|
3.2 (1)
|
|
Certificate of Amendment to Articles of Incorporation
|
|
|
|
3.3 (1)
|
|
Certificate of Amendment to Articles of Incorporation
|
|
|
|
3.4 (2)
|
|
Certificate of Amendment to Articles of Incorporation
|
|
(1)
|
Incorporated by reference from First
Amendment to our Registration Statement on Form SB-2 filed with the Commission on June 29, 2001.
|
|
(2)
|
Incorporated by reference from our Current Report on Form 8-K filed with the Commission on July 26, 2005.
|
SIGNATURE
Pursuant to the requirements
of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
Immunotech Laboratories, Inc.
|
|
|
|
|
|
|
Dated: June 12, 2013
|
/s/ Harry Zhabilov
|
|
By: Harry Zhabilov
|
|
Its: President
|
|
|
Immunotech Laborator (CE) (USOTC:IMMB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Immunotech Laborator (CE) (USOTC:IMMB)
Historical Stock Chart
From Aug 2023 to Aug 2024